NewAmsterdam Pharma Company N.V. (NAMSW) Operating margin 2022–2025
NewAmsterdam Pharma Company N.V. (NAMSW) operating margin by fiscal year — reported operating income divided by reported revenue.
-1002.9%FY2025 · since FY2022: -3.5% → -1002.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1002.9% | -616.0 pp |
| FY2024 | -386.9% | +911.6 pp |
| FY2023 | -1298.6% | -1295.1 pp |
| FY2022 | -3.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice